Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,904 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM; JEWEL Study Group. Richard Hobbs FD, et al. Among authors: harvey p. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19407658 Clinical Trial.
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM; JEWEL Study Group. Hobbs FD, et al. Among authors: harvey p. Int J Cardiol. 2006 Jun 16;110(2):242-50. doi: 10.1016/j.ijcard.2005.10.017. Epub 2005 Dec 9. Int J Cardiol. 2006. PMID: 16338012
A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA, Harvey P, Herfert O, Dykstra G, Jukema JW, Sun F, Gillen D. Preston RA, et al. Among authors: harvey p. J Clin Pharmacol. 2007 Dec;47(12):1555-69. doi: 10.1177/0091270007307879. J Clin Pharmacol. 2007. PMID: 18048574 Clinical Trial.
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results.
Kjeldsen SE, Sica D, Haller H, Cha G, Gil-Extremera B, Harvey P, Heyvaert F, Lewin AJ, Villa G, Mancia G; DISTINCT Investigators. Kjeldsen SE, et al. Among authors: harvey p. J Hypertens. 2014 Dec;32(12):2488-98; discussion 2498. doi: 10.1097/HJH.0000000000000331. J Hypertens. 2014. PMID: 25144296 Free PMC article. Clinical Trial.
Design, Synthesis, and Structure-Activity Relationships of Novel Peptide Derivatives of the Severe Acute Respiratory Syndrome-Coronavirus-2 Spike-Protein that Potently Inhibit Nicotinic Acetylcholine Receptors.
Hone AJ, Santiago U, Harvey PJ, Tekarli B, Gajewiak J, Craik DJ, Camacho CJ, McIntosh JM. Hone AJ, et al. Among authors: harvey pj. J Med Chem. 2024 May 30. doi: 10.1021/acs.jmedchem.4c00735. Online ahead of print. J Med Chem. 2024. PMID: 38814877
Aspartic acid mutagenesis of αO-Conotoxin GeXIVA isomers reveals arginine residues crucial for inhibition of the α9α10 nicotinic acetylcholine receptor.
Luo A, He J, Yu J, Wu Y, Harvey PJ, Kasheverov IE, Kudryavtsev DS, McIntosh JM, Tsetlin VI, Craik DJ, Zhangsun D, Luo S. Luo A, et al. Among authors: harvey pj. Int J Biol Macromol. 2024 May 19;271(Pt 1):132472. doi: 10.1016/j.ijbiomac.2024.132472. Online ahead of print. Int J Biol Macromol. 2024. PMID: 38772455
1,904 results